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Abstract
Background: The human umbilical cord contains mucoid connective tissue and fibroblast-like cells. These cells named 
Wharton's jelly cells, (WJCs) display properties similar to mesenchymal stem cells therefore representing a rich source 
of primitive cells to be potentially used in regenerative medicine.
Results: To better understand their self-renewal and potential in vitro expansion capacity, a reference 2D map was 
constructed as a proteomic data set. 158 unique proteins were identified. More than 30% of these proteins belong to 
cytoskeleton compartment. We also found that several proteins including Shootin1, Adenylate kinase 5 isoenzyme and 
Plasminogen activator-inhibitor 2 are no longer expressed after the 2nd passage of in vitro replication. This indicates that 
the proliferative potency of these cells is reduced after the initial stage of in vitro growing. At the end of cellular 
culturing, new synthesized proteins, including, ERO1-like protein alpha, Aspartyl-tRNA synthetase and Prolyl-4-
hydroxylase were identified. It is suggested that these new synthesized proteins are involved in the impairment of 
cellular surviving during replication and differentiation time.
Conclusions: Our work represents an essential step towards gaining knowledge of the molecular properties of WJCs 
so as to better understand their possible use in the field of cell therapy and regenerative medicine.
Background
Since the first identification of non-hematopoietic stem
cells in the bone marrow as colony-forming unit-fibro-
blasts (CFU-Fs) and the detailed characterization and
description of the tri-lineage potential of the mesenchy-
mal stem cells (MSCs), our knowledge of the molecular
properties of these cells has made great progress [1,2].
MSCs have a great appeal for tissue engineering and ther-
apeutic applications because of their high in vitro expan-
sion potential, self renewal capacity and multi-
potentiality [3-5]. However, considering the invasive pro-
cedure related to their availability, there is an increasing
interest in investigating the presence of MSCs in adult
and fetal sources and especially their presence in fetal
membranes such as umbilical cord matrix [6-9].
In the umbilical cord two arteries and one vein, sur-
rounded by mucoid connective tissue, called Wharton's
jelly are present (figure 1). It contains fibroblast-like cells
(WJCs), which show properties similar to the MSCs and
may represent a rich source of primitive cells [10,11]. Like
bone marrow stromal cells, WJCs are plastic adherent,
positively stained for markers of the mesenchymal cells
and negatively stained for markers of the hematopoietic
lineage [10-14].
WJCs can be expanded longer than MSCs before its
multeplicity is compromised [11]. For this reason they
could be induced to form different cellular lineages i.e.
adipose tissue, bone, cartilage, skeletal muscle cells, car-
diomyocyte-like cells and neural cells enabling them to be
used in biomedical engineering applications [15-17].
The aim of the present work was to build a 2D reference
map as a proteomic dataset, useful to define the molecu-
lar characteristics of WJCs and also to discover a number
of candidate biomarkers specifically expressed in these
extra-embryonic stem cells. In addition we also studied
the molecular change that occurs during the WJCs in
vitro growth in order to find proteins possibly related to
their long expansion ability and fast growth in vitro.
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Methods
Isolation and cell culture
For cell culture institutional review board approval was
obtained for all procedures. With the consent of the par-
ents, fresh human umbilical cords were obtained from
full-term births, aseptically stored in sterile saline and
processed within 6 hours from partum to obtain the
umbilical cord matrix mesenchymal stem cells. After
removal of blood vessels, the abundant extracellular
matrix of Wharton's jelly was scraped off with a scalpel,
finely cut and centrifuged at 250 × g for 5 minutes at
room temperature and the pellet was washed with serum-
free Dulbecco's modified Eagle's medium (DMEM). Next,
the cells were treated with collagenase (2 mg/ml) (Sigma)
for 16 hours at 37°C, washed in PBS(1X), and treated with
2.5% trypsin for 30 minutes at 37°C under agitation
(Wang, Sarugaser). Finally, the cells were washed in
PBS(1X) and seeded in complete growth medium
(HMSCGM) with growth supplements, all from Cambrex
Bio Science (now Lonza, Walkersville, Inc., Walkersville,
MD), in 5% CO2 in a 37°C incubator (ref Sarugaser, Weiss,
Mitchell). The cells were cultured with the medium
exchange every 3-4 days until reaching the confluence.
The adherents cells were detached with 0,05% trypsin-
EDTA, counted with Trypan Blue exclusion, and re-
seeded at 3000 cells/cm2 to reach the 90% of confluence
after 3-4 population doublings.
Immunophenotype
The WJCs from Wharton's jelly after the harvesting at the
different experimental times (2nd, 4th, 8th and 12th culture
passages) were immediately treated with 0.05% trypsin-
EDTA and incubated with 1 μg/106 cells fluorescein isoti-
ocynate (FITC)-conjugated or phycoerythryne (PE)-con-
jugated antibodies for 40 minutes at 4°C in the dark. The
anti-CD73, anti-CD13, anti-CD90, anti-CD117, anti-
CD14, anti-CD34, anti-CD105 and anti-CD45 (Becton
Dickinson, San Jose, CA, USA), anti-CD29, anti-CD44
and anti-CD166 (Ancell, Bayport, MN, USA) antibodies
were used. After washing, cells were analyzed on a flow
cytometer (FACSCalibur, Becton Dickinson, San Jose,
CA, USA) collecting 10,000 events and the data analyzed
by Cell Quest Software (Becton Dickinson, San Jose, CA,
USA).
Cell cycle
5 × 105 cells/sample for each passage were fixed by adding
500 μl of 70% cold ethanol and then stored at 4°C. After
24 h cells were washed and stained by adding 500 μl of a
solution containing 50 μg/ml propidium iodide (PI) and
200 μg/ml RNase. Cells were incubated for 3 h at 4°C in
the dark and acquired on a FACSCalibur flow cytometer
using the CellQuest™ software (both from Becton Dickin-
son, USA). Debris was excluded from the analysis by gat-
ing a forward scatter versus side scatter plot. Cell
aggregates were excluded by gating FL2 area versus FL2
width. The low flow rate mode (about 400-500 events/
second) was used to record 10,000 non-debris events for
each sample. PI fluorescence data were collected using
linear amplification. DNA content was assessed, placing
the G1 peak around the channel 400. Finally, data were
analysed using ModFit LT™ software (Verity Software
House, Toshan, ME, USA).
Telomere length assay
DNA extraction was performed using Wizard Genomic
DNA Purification Kit (Promega) following the manufac-
turer's instructions. The length of telomere regions of
genomic DNA was assessed on DNA from cells at differ-
ent passages using the Telo TAGGG kit (Roche) accord-
ing to the manufacturer's instructions. Appropriate
controls, DNA extracted from cells with long or short
telomere regions, were also provided with the kit.
Determination of cell senescence
The amount of senescent cells was evaluated at different
conditions by the use of the Senescence β-Galactosidase
Staining Kit (Abcam, Cambridge, UK) in accordance to
the manufacturer's instructions. Thus, the cells at differ-
ent experimental conditions (2nd, 4th, 8th and 12th passage)
were plated a density of 10,000 cells/cm2 for 24 h before
senescence-associated β-galactosidase staining. After
completion of the staining procedures, 5 representative
images were taken from diverse areas of each cell culture,
using phase-contrast microscopy to asses the number of
positive cells.
Adipogenic differentiation
To induce adipocyte differentiation, 20 × 103 cells/cm2
was cultured in DMEM high glucose (HG) (Sigma) sup-
plemented with 10% FBS, 0.5 mM isobutyl-methylxantine
(Sigma), 200 μM indomethacin (Sigma), 1 μM dexame-
Figure 1 Umbilical Cord Compartment. Digital photo of human 
umbilical cord tissue. Traverse section through an umbilical cord after 
birth. Scale bar = 2 mm. Wharton's Jelly is the connective tissue includ-
ed between the subamnion and the perivascular regions.Angelucci et al. Proteome Science 2010, 8:18
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thasone (Sigma) and 10 μg/ml insulin (Sigma). The cells
were cultured, replacing the medium every 2-3 days.
After 2-3 weeks of culture, the cells contained neutral lip-
ids in fat vacuoles; they were fixed in 10% formalin and
stained with fresh oil red-O solution (Sigma).
Osteogenic Differentiation
To induce osteogenic differentiation, 3 × 103 cells/cm2
was cultured in MEM (Sigma) supplemented with 10%
FBS, 10 mM β-glycerophosphate (Sigma), 0.2 mM ascor-
bic acid (Sigma), and 10 nM dexamethasone (Sigma), and
cultured for 3-4 weeks, replacing the medium every 2-3
days. To demonstrate osteogenic differentiation, the cul-
tures were fixed and subjected to alkaline phosphatase.
Chondrogenic Differentiation
To induce chondrogenic differentiation, aliquots of 2.5 ×
105 cells were pelleted in polypropylene conical tubes in
0.5 ml of DMEM HG containing 6.25 μg/ml insulin
(Sigma), 6.25 g/ml transferrin (Sigma), 6.25 g/ml selenous
acid (Sigma), 5.33 μg/ml linolenic acid (Sigma), 1.25 mg/
ml BSA (Sigma), 0.35 mM proline (Sigma), 1 mM sodium
pyruvate (Sigma), 100 nM dexamethasone (Sigma), 0.1
mM L-ascorbic acid-2-phosphate (Sigma), supplemented
with 10 ng/ml transforming growth factor-beta 3 (TGF-
β3) (R&D Systems, Minneapolis, MN). This medium was
replaced every 3-4 days for 3-4 weeks. Pellets were forma-
lin-fixed, embedded in paraffin, morphologically exam-
ined after toluidine blue staining.
Proteome characterization
To generate 2D map of WJCs and analyze their protein
changes during culture condition we chose four passages
(2nd, 4th, 8th and 12th) in vitro expansion that were pro-
cessed for protein extraction. For all culture passages we
considered three independent donors and we ran 3 gels
for each biological replicate. 16 × 106 stem cells of each
population were treated with lysis buffer (40 mM Tris pH
7.4, 8 M urea, 4% CHAPS) supplemented with protease
inhibitor mixture and 2 mM TBP as reducing agent. Pro-
tein concentration was determined by using the Bradford
assay with bovine serum albumin (BSA) as standard [18].
The lysated samples were loaded onto commercial 4-7
IPG strip and the second dimension was performed on a
9-16% acrylamide gel. Analytical gels were stained with
ammoniacal silver nitrate, while gels used for MALDI-
TOF MS protein identification were silver-stained with-
out glutaraldehyde, according to the mass compatible
method described by Shina et al. [19,20]. After staining,
gels were scanned with a MagicScan scanner (GE Health-
care, formerly Amersham Biotech, Uppsala, Sweden) in
transparency mode at 800 dpi and the images were stored
as TIFF images. Once digitized, the gel images were ana-
lyzed with Image Master 2D platinum software, 6.0 ver-
sions (GE Healthcare, formerly Amersham Biotech,
Uppsala, Sweden). A positional gel calibration was car-
ried out by using a 2D calibration method included in the
analysis package that calculates the position of protein
spots in terms of their isoelectric point (pI) and Molecu-
lar Weight (MW) values. Several spots, Thioredoxin (pI
5.13-47.09 kDa), Endoplasmin (pI 4.60-90.13 Da), spec-
trin alpha chain (pI 5.6-118.17 kDa), 75 kDa glucose regu-
lated protein (pI 6.2-74.02 kDa), Glycerol-3-phosphate
dehydrogenase (pI6.1 -38.65 kDa), distributed through-
out the reference gel and identified by mass spectrometry
analysis were chosen as marker proteins. Then a protein
list including these marker proteins was created and pI
and MW were calibrated in all maps simultaneously by
interpolating between the known pI and MW values of
the markers. In order to construct a synthetic gel from all
conditions included in the present study three different
gel runs for each sample were performed and then sub-
jected to image analysis with Image Master 2D evolution
software (Ge Healthcare, formerly Amersham Biotech,
Uppsala, Sweden). A spot was considered only if it was
detected in three out of all experimental replicates for
each sample and defined "common spot" (i.e. always pres-
ent and in the same position on all gels). The quantity of
each spot was normalized with respect to the total spot
volume detected in the gel. Relative spot volumes were
determined by modelling the optical density in individual
spot segments using a two-dimensional Gaussian analy-
sis.
Following gel analysis, protein spots on preparative
WJCs 2-DE gels were excised and analyzed by the peptide
mass finger printing (PMF) approach on a MALDI-TOF
MS. Protein spots, once excised from the gel, were
washed with 100% ethanol and 100 mM ammonium
bicarbonate (NH4HCO3). The pieces of gel correspond-
ing to a single protein were incubated for 60 min at 56°C
in a volume of 50 mM NH4HCO3 supplemented with 10
mM DTT and then for 30 min in the dark in 55 mM iodo-
acetamide in 100 mM NH4HCO3 at room temperature.
Finally, the gel was reswollen in 50 mM NH4HCO3 con-
taining trypsin and incubated at 37°C overnight [21]. Pep-
tide extract was applied to a C18ZipTip (Millipore,
Bedford, MA, USA), rinsed with a 0.1% TFA and eluted
directly on the MALDI target with 0.5 μl of a saturated α-
cyano-4-hydroxycinnamic acid (1:1 = ACN: 0.1% TFA)
solution.
For all MS analysis, PMF was obtained using REFLEX-
IV MALDI-TOF (Bruker Daltonics, Germany) in the
reflectron operation mode at a potential of 20 kV and a
delayed extraction of 400 ns. The instrument was cali-
brated with external standards such as bradykinin (frag-
ment 1-7) 757,39 m/z, angiotensin II 1046,54 m/z, ACTH
(fragment 18-39) 2465,19 m/z, Glu Fibrinopeptide B
1571,57 m/z, and renin substrate tetradecapeptide por-Angelucci et al. Proteome Science 2010, 8:18
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cine 1760,02 m/z. Each spectrum was produced by accu-
mulating data from 100 laser shots over the m/z range of
700-3000 Da. All mass spectra were calibrated internally
by trypsin (Promega Bioscience, CA) autolysis products
at 842, 50 Da, 1.046,56 Da, 2.212,11 Da and 2.284,19 Da.
Trypsin and keratin contamination peaks were excluded
from the peak list used in the database searching.
The results from the PMF were employed to search the
human NCBIn protein database by Mascot search engine,
which compare the experimentally determined tryptic
peptide masses with theoretical peptide masses calcu-
lated for protein from these databases. Search parameters
are as follows: type of search, peptide mass fingerprint;
enzyme, trypsin; fixed modification, carbamidomethyla-
tion (Cys); variable modifications, oxidation (Met); mass
values, monoisotopic; peptide charge state, 1+; maximum
missed cleavages, 1; and peptide mass tolerance, 100
ppm.
Confirmation of the proteins expressed by WJCs at the
2nd and 12th culture passages was made by Western blot
analysis in the 1D and 2D mini system. WJCs samples at
2nd and 12th passages were extracted and centrifuged. An
equal protein amount of 10 μg for 1D from each total cel-
lular lysate was loaded into 9-16% SDS-PAGE and was
electrophoretically transfererred into nitrocellulose
membranes at 100 V overnight at 4°C. For 2D Western
blot 20 μg of WJCs cells at 2nd and 12th passages were sep-
arated on 7 cm pH 4-7 IPG strip (GE Healthcare, for-
merly Amersham Biotech, Uppsala Sweden). IEF was
performed by a 12 h in gel-rehydratation mode at 50V,
followed by focusing at 5000 V for a total of 20 kVh. The
strips were incubated in equilibration buffer (8 M urea,
2% SDS, 30%(v/v) glycerol, 50 mM Tris-HCl, pH8.8)
reduced with 1% (w/v) DTT for 15 min and alkylated with
2.5% iodacetamide for 15 min in dark. The 2D running
was made into 9-16% SDS-PAGE and the electrophoresed
proteins were transferred to nitrocellulose at 200 V over-
night at 4°C. Primary antibodies sources and dilutions
were: rabbit polyclonal antibodies against ADK5 1:100
(Abcam, Cambridge Science Park, UK), PAI2 1:1000
(Abcam, Cambridge Science Park, UK), SHOT1 1:500
(Cell Signalling Technology inc., Denver, MA), ERO1A
1:1000 (Abcam, Cambridge Science Park, UK), P4HA1
1:1000 (Abcam, Cambridge Science Park, UK), P4HA2
1:1000 (Abcam, Cambridge Science Park, UK), VIME
1:1000 (Abcam, Cambridge Science Park, UK), chicken
polyclonal antibody against EIF3I 1:2000 (Abcam, Cam-
bridge Science Park, UK), and mouse monoclonal anti-
body against ACTB 1:1000 (Santa Cruz Biotechnology,
Santa Cruz, CA). Secondary antibodies diluted 1:6000
were goat polyclonal to rabbit IgG (for ADK5, PAI2,
SHOT1, ERO1A, P4HA1, P4HA2 and VIME) rabbit poly-
clonal to chicken IgY (for EIF3I) and goat polyclonal to
mouse IgG (for ACTB), all conjugated with horseradish
peroxidase (Abcam, Cambridge Science Park, UK). Signal
detection was performed with an ECL plus kit (GE
Healthcare formerly Amersham Biotech, Uppsala, Swe-
den) and visualized by autography on Biomax light film
(Sigma Chemical, St. Louis, MO, USA). All blot experi-
ments were performed at least three times.
Result and Discussion
Cellular isolation, culturing and characterization
As can be seen in figure 2A, the cells isolated from the
human Wharton's jelly and used in the present work, dis-
play a consistent spindle-shaped elongated morphology
similar to fibroblastoid cells. This feature appears to be
maintained up to the end of culturing. A representative
immunophenotype of the cells used in our experiment is
reported in figure 2B. A positive response for CD105
(endoglin), CD73, CD90, CD29, CD166, CD13, CD44
(hyaluronan receptor) markers and a negative reactivity
for CD34, CD45 and CD14 hematopoietic markers were
d e t e c t e d  a t  e a c h  t i m e  o f  c u l t u r e  p a s s a g e s .  T h i s  h i g h
homogeneous expression of the above mentioned mark-
ers suggests that the samples used in the present study
were not significantly contaminated by no-stem cell pop-
ulation (figure 2B). Figure 2C illustrates the ability of
WJCs to differentiate in osteogenic, adipogenic and
chondrogenic lineages further evidencing their pluripo-
tency.
As reported in figure 2D cells, after expansion, showed
a homogeneous diploid content in the G1 cell-cycle
phase. Furthermore, in figure 2D it can be also seen that
the G1 and the G2 cell-cycle checkpoints appeared intact.
This finding is consistent with cells actively cycling. The
long telomeric end of DNA extracted from cells at all pas-
sages examined also confirms that these cells preserve
their capability to undergo a high number of cellular divi-
sions up to the 12th passage (figure 2E). Accordingly, a low
frequency of β-galactosidase positive staining cells was
found in all different passages (2nd, 4th, 8th  and 12th)
(Additional file 1). Overall, the data reported in figure 2
strongly indicate that the cells derived from Warthon's
jelly belong to the mesenchimal stem-cell population.
In order to characterize the proteome profile of WJCs,
the cells prepared at the 2nd, 4th, 8th and 12th culture pas-
sages were analyzed. Longer term in vitro culture passage
led to an impairment of the cell expansion ability as
accounted by the cell number count (figure 2F) and by the
analysis of the doubling time (figure 2G). For these rea-
sons they were not included in the present investigation.
2DE analysis and MS protein identification
The master gels of the 2nd, 4th, 8th and 12th passage con-
structed for each step are reported in figure 3, by using
cells prepared from three different human donors. On
average 2450 ± 76, 2330 ± 91, 2200 ± 103 and 1750 ± 74Angelucci et al. Proteome Science 2010, 8:18
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spots were detected from the 2nd to the 12th  in vitro
expansion passages respectively (Additional file 2).
In order to evaluate the change of protein pattern
expression occurring during in vitro cell expansion, the
master gels, resulting from each culture passages, were
compared with the synthetic gel constructed by using the
gels resolved from all culture passages (figure 3).
Image analysis of the synthetic gel (figure 4A) revealed
the presence of 2150 spots. Since these spots are common
to all passages they can therefore be considered house-
Figure 2 WJCs characterization. A. Light microscopic micrographs of WJCs in monolayer culture. In monolayer culture, the cells assumed a poly-
morphic, fibrobroblast-like morphology, which was maintained throughout the passaging processes. 10 days (left panel), 15 days of culture (central 
panel) and cells at passage 1, prior to reach confluence (right panel). Original magnification ×100. B. Analyses of surface antigen marker by flow 
cytometry. Cell suspensions were stained with specific mouse anti-human monoclonal antibodies (Mabs) as indicated in filled histograms. The empty 
histogram is the respective IgG isotype control. C. Ability to differentiate into several lineages. Osteogenic differentiation (left panel) was indicated 
by the increase in alkaline phosphatase (magnification 200×). Adipogenic differentiation (central panel) is visually marked by accumulation of neutral 
lipid vacuoles in cultures (red oil staining) (magnification 200×). Chondrogenic differentiation (right panel) is visually marked by toluidine blue staining 
(magnification 100×). D. Flow cytometry of cells showing DNA stained with propidium iodide. G1 and G2/M indicate 2n and 4n cellular DNA content, 
respectively. S indicates cells undergoing DNA synthesis, intermediate in DNA content between 2n and 4n. In the phase contrast image, arrow indi-
cates one mitotic event. E. Telomere length assay on WJCs at different culture passages. The maintenance of long telomeres is a key feature of stem 
cells, ensuring the capability to undergo several cell cycles of replication. Molecular weight marker (M), control DNA with short telomeres (S) and con-
trol DNA with long telomeres (L). p4, p8 and p12 DNA extracts from WJCs at different 4th 8th and 12th passages showing long telomeric ends. F, G. 
Growth Features of WJCs during expansion period. Proliferation (F) and doubling time (G) at different passages of WJCs in vitro culture calculated 
by Trypan blue exclusion test.Angelucci et al. Proteome Science 2010, 8:18
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keeping proteins. 251 out of 2150 spots were picked for
mass spectrometry analysis. 183 spots, representing 158
unique proteins with a molecular mass ranging from 12
kDa to 180 kDa and with an isoelectric point in the 4-7
pH range were identified. The list of assigned proteins are
indicated in the 2D map (figure 4A) and reported in
A d d i t i o n a l  f i l e  3 .  T h e  i d e n t i f i e d  p r o t e i n s  c o u l d  b e
included into at least five functional categories (figure
Figure 3 WJCs 2D map. Silver-stained 2D gels (pH4-7, 9-16% acrylamide, 200 μg protein loading) from the 2nd, 4th, 8th and 12th in vitro expansion pas-
sages. The synthetic gel is the result of the comparative analysis between the master gels obtained from 3 gels for each culture passage.Angelucci et al. Proteome Science 2010, 8:18
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4B), i.e. cytoskeleton and motility, metabolism, protein
biosynthesis folding and degradation, nucleotide biosyn-
thesis and cell signaling. Overall 60% of total proteome
have been identified as proteins belonging to the
cytoskeleton compartment and involved in protein bio-
synthesis, folding and degradation. The great number of
proteins of these two groups may probably give to WJCs
the proliferative capacity for the quickly change of their
phenotype in response to adequate external stimuli.
The large number of proteins associated with the ener-
getic metabolism may confer to WJCs the necessary
power for their intense proliferation. Antioxidant pro-
teins such as thioredoxin, peroredoxin and gluthatione
transferases, are also present in these cells. They may play
a key role in preserving WJCs from oxidative injury dur-
ing in vitro expansion.
Proteins involved in nucleotide biosynthesis and signal
transduction seem to be poorly represented in WJCs. It
has to be noted that myocyte's characterizing proteins
like caldesmon, α-actinin, tropomyosin, and vinculin are
expressed up to the last culture passages [22]. Further-
more cardiomyogenic and hepatic putative markers such
as tropomyosin and pyruvate kinase were also detected in
these cells [23-26].
The presence of vimentin (VIME), which is the most
ubiquituos intermediate filament protein and the first
protein to be expressed during cell differentiation is com-
mon to other MSCs such as bone marrow and cord blood
derived non-hematopoietic (mesenchymal, stromal) pro-
genitor cells, fibroblasts and endothelial cells [27,28].
VIME is one of the most prominent phosphoprotein
present in MSCs and its phosphorylation is significantly
enhanced during cell division [29,30]. Six different iso-
forms of phosphorilated VIME were identified in WJCs.
However, one of them i.e. Vimentin 4.9/47.4 (table 1; fig-
ure 5F) was no longer expressed after the 2nd passage,
whereas another one i.e. Vimentin 5.1/45.7 (table 2; figure
5F) appeared only at the end of the last culture passage.
It is interesting to note that proteins reported to be
markers of MSCs such as Annexin 1, Annexin 2, or heat
shock protein 27 b (HSP27 b) and proteins considered
markers for hESCs such as elongation factor Tu (TUFM),
isocitrate dehydrogenase (IDH1), peroxiredoxins 1, 2, and
6 (PRDX1, PRDX2, PRDX6) are simultaneously expressed
Figure 4 WJCs shyntetic gel (A) and the functional grouping of identified proteins (B). In the Figure 4B values represent the percent distribution 
of proteins classified by biological process of gene ontology terms into functional categories.Angelucci et al. Proteome Science 2010, 8:18
http://www.proteomesci.com/content/8/1/18
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Figure 5 Panel A and B indicate proteins no longer expressed after the 2nd passage. Protein spots detected by image analysis (A) are indicated 
with circles, whereas the proteins assigned by PMF analysis are annotated with the abbreviation name; the magnified views and peptide mass spec-
trum of spots 2, 22, 34, 35, 36, 61, 67 and 75 are indicated (B). Panel C and D indicate proteins spots expressed at the 12th passage. All detected 
spots are indicated with circles, whereas the identified protein spots are designed with the abbreviation name (C); the magnified views and peptide 
mass spectrum of spots 5, 16, 17,31 and 43 are indicated (D). Panel E and F indicate immunoblot analysis of the WJCs protein only expressed 
at the 2nd and at the 12th passages. 1-D gels probed with antibodies raised against KAD5, EIF31, PAI2, SHOT1, ERO1, PHA1 AND PHA2 (E). 2D blot 
analysis raised against ACTB and VIME at the 2nd and 12th passages (F).Angelucci et al. Proteome Science 2010, 8:18
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in WJCs [31]. Furthermore, WJCs contain nuclesphos-
min, a nucleolus protein, which is highly expressed in
proliferating cell as well as in undifferentiated hESCs [32-
35]. Two signal transduction proteins, i.e. 14-3-3 protein
zeta/delta and Twinfillin-like protein 2, not yet found in
any of the stem cell lines so far investigated, are present in
WJCs. The possibility that they may be WJCs specific
proteins needs to be further investigated. The gel match-
ing between the master gels and the synthetic gel has
allowed to detect 47 proteins that were no longer
expressed after the initial passages (figure 5A).
8 out of 47 were assigned by PMF (figure 5B) and six of
them were validated by Western blotting experiments
(table 1 and figure 5E, F). These proteins are involved in
important cellular physiological functions including pro-
tein biosynthesis, cellular division, internal cellular motil-
ity and neuronal differentiation.
Shootin 1 (SHOT1) and two Adenylate Kinase 5 isoen-
zymes (KAD5) have been identified as brain specific pro-
teins that may play a key role in neurogenesis [36-38].
The eukaryotic translation initiation factor 3 subunit 1
(EIF3I) has an essential role in the rate-limiting initiation
phase of translation and is required for several steps in
the initiation of protein synthesis [39]. Although the
physiological role of Plasminogen activator inhibitor 2
(PAI2) has not yet been well defined, several intracellular
functions, including capacity to alter genes expression,
ability to influence the cellular proliferation and differen-
tiation or inhibition of apoptosis, have been attributed to
this protein [40,41].
The inability of WJCs to express, after the initial stage
of replication, specific proteins involved in neuronal dif-
ferentiation, may indicate that WJCs are progressively
reducing their differentiation capacity during in vitro
expansion.
Gel matching analysis has also allowed to identify 27
new proteins that appear only at the end of culturing (fig-
ure 5C).
5 out of 27 (table 2) were assigned by PMF (figure 5D)
including two isoforms of Prolyl-4-hydroxylase i.e. the
subunit alpha-1(4PHA1) and the subunit alpha-2
(4PHA2). Western blotting analysis was carried out on
them and on ERO1-like protein alpha; the data obtained
are shown in figure 5F.
4PHAs promote the post-translational formation of 4-
hydroxyproline in hypoxia-inducible factor (HIF) alpha
proteins which physiologically regulates a broad range of
relevant cellular functions including apoptosis, cellular
survival and energy metabolism [42]. 4PHAs are consid-
ered cellular oxygen sensors able to modulate the cellular
response towards hypoxia [43-45].
In addition, these enzymes are involved in the intracel-
lular collagen maturation by catalyzing the hydroxylation
of proline residues of the procollagen. Their presence
Table 1: Proteins no longer expressed after the 2nd culture passage.
Spot # Abbr. 
Name
ACa Protein Name Scoreb SCc % pI Mr(Da) 
Theo.
pI Mr(Da) 
Exp.
2 PAI2 P05120 Plasminogen 
activator 
inhibitor 2
123 46 5,46 46596 5,44 30700
22 SHOT1 A0MZ66 Shootin 1 56 39 5,27 72109 4,80 50629
34 EIF3I Q13347 Eukaryotic 
translation 
initiation factor 
3 subunit I
214 61 5,38 36502 5,21 34955
35 ACTG P63261 Gamma Actin 68 32 5,31 41792 4,98 32910
36 ACTB P60709 Beta Actin 96 58 5,29 41736 5,04 33210
61 KAD5 Q9Y6K8 Adenylate 
kinase 
isoenzyme 5
81 37 5,23 22420 4,80 28831
67 VIME P08670 Vimentin 100 35 5,06 53651 4,95 47492
75 KAD5 Q9Y6K8 Adenylate 
kinase 
isoenzyme 5
79 54 5,23 22420 4,70 27829
A) Entry code number from SWISS PROT database.
B) Score is -10*Log(P), where P is the probability that the observed match is a random event, it is based on Swiss-Prot database using the MASCOT 
searching program as MALDI-TOF data.
C)Sequence coverage means the ratio of portion sequence covered by matched peptide to the full length of the protein sequence.Angelucci et al. Proteome Science 2010, 8:18
http://www.proteomesci.com/content/8/1/18
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may probably be a consequence of the impairment of the
cellular expansion ability that occurs to WJCs at the end
of cellular in vitro expansion (figure 2F, G).
A c c o r d i n g l y ,  M i y a i s h i  e t  a l .  h a v e  f o u n d  t h a t  h u m a n
fibroblasts at low population doubling rate increase the
level of 4PHA1 and 4PHA2 expression [46].
At the end of culturing we have also found ERO1-like
protein alpha (ERO1A). This enzyme is responsible for
ROS cellular production during oxidative stress [47-49].
It is well known that ROS are considered the major con-
tributors to cellular aging [50]. This protein, induced by
hypoxia and regulated via HIF-pathway may play a key
role in the maintenance of cellular redox homeostasis.
An interesting protein we have found to be expressed
only at the end of culture expansion is the Aspartyl-tRNA
synthetase. This enzyme interacting with differentiation-
related gene 1 protein has a growth inhibitory role on cel-
lular proliferation [51].
Taking into account the functional roles attributed to
these proteins, it cannot be excluded that they are related
to the molecular mechanism of WJCs in vitro self-
renewal and multipotency.
Conclusion
In this report we describe an extensive study of human
WJCs proteome profiling. Several important proteins,
including shootin 1, adenylate kinases 5 isoenzyme and
plasminogen activator inhibitor 2, are no longer
expressed after the early stage of cellular in vitro replica-
tion. This is probably correlated with the gradual reduc-
tion of their staminal multipotency. In addition, at the
end of the cellular expansion, new proteins probably
involved in the impairment of cellular survival during
replication and differentiation time were identified.
These proteins could be related to the biological cellular
mechanism occurring in the cellular WJCs in vitro senes-
cence.
Further investigation will be needed to elucidate bio-
logical mechanisms involved in maintaining active prolif-
eration and maximal cellular plasticity in order to
optimize in vitro culturing procedure.
WJCs obtained from the Wharton jelly umbilical cord
therefore appear to be an inexpensive biological source
for the isolation of stem cells thus circumventing the eth-
ical constraint that arises from the use of the embryonic
tissue.
In this context, this study carried out to increase the
knowledge about the molecular features of WJCs, may
give a great contribution to the field of regenerative med-
icine.
Additional material
Additional file 1 β-galactosidase staining at different passages in 
vitro expansion. β-galactosidase staining at the 2nd (A), 4th (B), 8th (C), 12th 
(D) passage in vitro expansion. Examples of positive cells are indicated by 
arrows (magnification 100×).
Table 2: New proteins expressed after the 12th culture passage.
Spot # Abbr. 
Name
ACa Protein 
Name
Scoreb SCc % pI Mr(Da) 
Theo.
pI Mr(Da) 
Exp.
5 VIME P08670 Vimentin 124 58 5,06 53651 5,09 45706
16 P4HA2 O15460 Prolyl 4-
hydroxylase 
subunit 
alpha-2
64 53 5,50 61623 5,50 61292
17 ERO1A Q96HE7 Oxidoreduc
tin-1-
Lalpha
98 71 5,43 55213 5,65 58342
31 SYDC P14868 Aspartyl-
tRNA 
synthetase, 
cytoplasmic
89 67 6,10 57700 6,09 57478
43 P4HA1 P13674 Prolyl 4-
hydroxylase 
subunit 
alpha-1
101 45 5,70 61157 5,12 62401
A) Entry code number from SWISS PROT database.
B) Score is -10*Log(P), where P is the probability that the observed match is a random event, it is based on Swiss-Prot database using the MASCOT 
searching program as MALDI-TOF data.
C) Sequence coverage means the ratio of portion sequence covered by matched peptide to the full length of the protein sequence.Angelucci et al. Proteome Science 2010, 8:18
http://www.proteomesci.com/content/8/1/18
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